Aspen Aerogels, Inc.
NYSE:ASPNConstruction
+$0.24 today
- Market cap
- $407.33M
- Beta
- 2.99
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$1.35
Volume 1.17M
Average 1.58M
ASPN Common Stock Issued
Cash raised by issuing new shares.
Aspen Aerogels, Inc.NYSE: ASPN
Common Stock Issued · Q1 FY2026 · quarter ended Mar 2026
Common stock issued outflow grows to $0
Q1 FY2026 common stock issued was $0, compared with $0 a year earlier. Trailing-twelve-month common stock issued was $478K. Over 3 fiscal years it compounded at -83.2% a year.
Context
- Common stock issued amounted to 0.7% of revenue in FY2025, down 20.0 pp from a year earlier.
- Common stock issued increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly common stock issued holds near $0 or moves back toward the trailing-twelve-month quarterly average of $119.5K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 1.87M USD
- Year-over-year change
- -98.0%
- 4-year CAGR
- -62.5%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.87M | -98.0% |
| FY2024 | 2024-12-31 | 93.84M | +22.6% |
| FY2023 | 2023-12-31 | 76.52M | -80.4% |
| FY2022 | 2022-12-31 | 391.3M | +314.4% |
| FY2021 | 2021-12-31 | 94.42M | — |
Common Stock Issued vs competitors
How ASPN compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock issued is compared through growth and share of revenue rather than absolute size.
- Common stock issued amounts to 0.2% of revenue for ASPN, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $978.67M USD | — | — | 164.6% | |
| LTM Mar 2026 | $182.08M USD | +350.6% | +155.7% | — | |
| LTM Dec 2025 | CN¥162.27M CNY | — | +32.4% | 38.8% | |
| FY2025 | €35.17M EUR | +4431.7% | — | 111.4% | |
| LTM Mar 2026 | $478K USD | — | -83.2% | 0.2% | |
| LTM Mar 2026 | $344.88K USD | -72.3% | +9.3% | 0.2% | |
| LTM Apr 2026 | $214K USD | -8.2% | -32.3% | 0.0% | |
| LTM Feb 2026 | $0 USD | — | — | 0.0% | |
| LTM Apr 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding ASPN) | — | +171.2% | +20.9% | 0.1% | |
Competitors are the stored peer set for ASPN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (37.09M) | (82.74M) | (45.81M) | 13.38M | (389.55M) |
| Depreciation & Amortization | 9.44M | 9.22M | 18.18M | 22.53M | 45.16M |
| Deferred Income Tax | (3.82M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 5.18M | 9.39M | 10.95M | 12.86M | 8.63M |
| Change in Working Capital | 6.03M | (38.17M) | (31.17M) | (50.96M) | 48.56M |
| Accounts Receivables | (4.64M) | (37.04M) | (12.55M) | (39.36M) | 70.3M |
| Inventory | 1.11M | (10.55M) | (16.65M) | (8.36M) | 9.3M |
| Accounts Payables | 7.38M | 5.32M | 4.58M | 7.34M | (19.45M) |
| Other Working Capital | 2.19M | 4.11M | (6.55M) | (10.58M) | (11.59M) |
| Other Non-Cash Items | 1.64M | 7.9M | 16.19M | 47.75M | 320.08M |
| Operating Cash Flow | (18.63M) | (94.4M) | (42.61M) | 45.55M | 32.87M |
| Capital Expenditures | (13.78M) | (177.97M) | (175.46M) | (86.26M) | (37.45M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (13.78M) | (177.97M) | (175.46M) | (86.26M) | (37.45M) |
| Debt Repayment | 0 | 100M | (623K) | 25.59M | (59.23M) |
| Common Stock Issued | 94.42M | 391.3M | 76.52M | 93.84M | 1.87M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.95M) | (12.93M) | (420K) | 2.59M | (765K) |
| Financing Cash Flow | 92.47M | 478.37M | 75.48M | 122.02M | (58.13M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 60.07M | 206M | (142.59M) | 81.31M | (62.71M) |
| Free Cash Flow | (32.41M) | (272.37M) | (218.07M) | (40.71M) | (4.58M) |
Aspen Aerogels, Inc.
NYSE:ASPN
Intrinsic Alpha fair value
Locked
Current Price
$4.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.